All News

    An Expert Shares Her Advice For Managing Side Effects in Cervical Cancer

    January 28th 2025, 2:00pm

    Video

    Dr. Ritu Salani shared her advice for patients undergoing advanced treatment options for their cervical cancer who are experiencing side effects.

    FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer

    January 28th 2025, 12:22am

    Article

    The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy.

    Palliative Care May Improve Quality of Life in Esophageal Cancer

    January 27th 2025, 10:00pm

    Article

    End-of-life palliative care consultations may also ease financial strain for patients with esophageal cancer.

    Understanding Food Insecurity and Malnutrition During Cancer Treatment

    January 27th 2025, 8:00pm

    Article

    Dr. Anna Arthur discusses how the NOURISH trial is addressing food insecurity and malnutrition in patients undergoing treatment for their blood cancers.

    When A Spouse Dies from Cholangiocarcinoma: Praise for Single Parents

    January 27th 2025, 6:00pm

    Article

    Despite the initial shock and challenges, I found strength and support within the community of single parents.

    Oral Liporaxel May Be Superior To Intravenous in Advanced Gastric Cancer

    January 27th 2025, 4:14pm

    Article

    Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a second-line therapy.

    How Subcutaneous vs IV May Affect Treatment Adherence in Cancer Care

    January 27th 2025, 2:00pm

    Article

    Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version for patients with solid tumors.

    Study Shows Poor Outcomes in BRAF V600E-Mutant Metastatic CRC

    January 26th 2025, 7:00pm

    Article

    Synchronous metastases did not affect survival in resected BRAF V600E-mutated metastatic colorectal cancer.

    The BREAKWATER Trial Explores Braftovi, Erbitux and Chemo in BRAF V600E+ mCRC

    January 26th 2025, 3:00pm

    Video

    Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ metastatic colorectal cancer.

    Neoadjuvant Keytruda Shows Significant Benefit in dMMR Colon Cancer

    January 25th 2025, 8:30pm

    Article

    Neoadjuvant Keytruda for patients with deficient DNA mismatch repair colon cancer resulted in a pathological complete response rate of 44%.